Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine

Overview

Journal J Pers Med

Date 2023 Mar 29

PMID 36983604

Authors

Mihaela Simona Popoviciu

Nirja Kaka

Yashendra Sethi

Neil Patel

Hitesh Chopra

Simona Cavalu

Affiliations

Soon will be listed here.

Abstract

Type 1 Diabetes Mellitus (T1DM) is a common hyperglycemic disease characterized by the autoimmune destruction of insulin-producing beta cells of the pancreas. Various attempts have been made to understand the complex interplay of genetic and environmental factors which lead to the development of the autoimmune response in an individual. T1DM is frequently associated with other autoimmune illnesses, the most common being autoimmune thyroid disorders affecting more than 90% of people with T1D and autoimmune disorders. Antithyroid antibodies are present in around 20% of children with T1D at the start of the illness and are more frequent in girls. Patients with T1DM often have various other co-existing multi-system autoimmune disorders including but not limited to thyroid diseases, parathyroid diseases, celiac disease, vitiligo, gastritis, skin diseases, and rheumatic diseases. It is a consistent observation in clinics that T1DM patients have other autoimmune disorders which in turn affect their prognosis. Concomitant autoimmune illness might affect diabetes care and manifest itself clinically in a variety of ways. A thorough understanding of the complex pathogenesis of this modern-day epidemic and its association with other autoimmune disorders has been attempted in this review in order to delineate the measures to prevent the development of these conditions and limit the morbidity of the afflicted individuals as well. The measures including antibody screening in susceptible individuals, early identification and management of other autoimmune disorders, and adoption of personalized medicine can significantly enhance the quality of life of these patients. Personalized medicine has recently gained favor in the scientific, medical, and public domains, and is frequently heralded as the future paradigm of healthcare delivery. With the evolution of the 'omics', the individualization of therapy is not only closer to reality but also the need of the hour.

Citing Articles

Systemic lupus erythematosus and pulmonary tuberculosis in a patient developing acute-onset type 1 diabetes.

Jinnouchi T, Henmi R, Watanabe K, Suyama Y, Sakama R, Idezuki T Diabetol Int. 2025; 16(1):175-181.

PMID: 39877438 PMC: 11769924. DOI: 10.1007/s13340-024-00772-z.

The Prevalence of Autoimmune Diseases Among Children With Type I Diabetes Mellitus.

AlMoosa E, Al Ghadeer H, Alatiya J, Aldairam W, Alhamrani A, Alarbash A Cureus. 2025; 16(12):e76272.

PMID: 39845243 PMC: 11753791. DOI: 10.7759/cureus.76272.

Enhanced Metabolic Control in a Pediatric Population with Type 1 Diabetes Mellitus Using Hybrid Closed-Loop and Predictive Low-Glucose Suspend Insulin Pump Treatments.

Bojoga I, Ioacara S, Malinici E, Chiper V, Georgescu O, Sirbu A Pediatr Rep. 2024; 16(4):1188-1199.

PMID: 39728741 PMC: 11677866. DOI: 10.3390/pediatric16040100.

Nicotinamide and Nicotinoyl-Gamma-Aminobutyric Acid as Neuroprotective Agents Against Type 1 Diabetes-Induced Nervous System Impairments in Rats.

Kuchmerovska T, Tykhonenko T, Yanitska L, Savosko S, Pryvrotska I Neurochem Res. 2024; 50(1):1.

PMID: 39527359 DOI: 10.1007/s11064-024-04257-y.

Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults.

Santoso C, Wei Y, Ahlqvist E, Tuomi T, Carlsson S Diabetologia. 2024; 68(2):331-341.

PMID: 39467873 PMC: 11732938. DOI: 10.1007/s00125-024-06303-4.

References

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2019; 43(Suppl 1):S14-S31. DOI: 10.2337/dc20-S002. View

Vivino F . Sjogren's syndrome: Clinical aspects. Clin Immunol. 2017; 182:48-54. DOI: 10.1016/j.clim.2017.04.005. View

Bhadada S, Kochhar R, Bhansali A, Dutta U, Kumar P, Poornachandra K . Prevalence and clinical profile of celiac disease in type 1 diabetes mellitus in north India. J Gastroenterol Hepatol. 2011; 26(2):378-81. DOI: 10.1111/j.1440-1746.2010.06508.x. View

Diamanti A, Capriati T, Basso M, Panetta F, Di Ciommo Laurora V, Bellucci F . Celiac disease and overweight in children: an update. Nutrients. 2014; 6(1):207-20. PMC: 3916856. DOI: 10.3390/nu6010207. View

Betz R, Petukhova L, Ripke S, Huang H, Menelaou A, Redler S . Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun. 2015; 6:5966. PMC: 4451186. DOI: 10.1038/ncomms6966. View

Kahaly G . Polyglandular autoimmune syndromes. Eur J Endocrinol. 2009; 161(1):11-20. DOI: 10.1530/EJE-09-0044. View

Burner T, Rosenthal A . Diabetes and rheumatic diseases. Curr Opin Rheumatol. 2008; 21(1):50-4. DOI: 10.1097/BOR.0b013e32831bc0c4. View

Fierabracci A . Type 1 Diabetes in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome (APECED): A "Rare" Manifestation in a "Rare" Disease. Int J Mol Sci. 2016; 17(7). PMC: 4964482. DOI: 10.3390/ijms17071106. View

Tozzoli R, Kodermaz G, Perosa A, Tampoia M, Zucano A, Antico A . Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev. 2010; 10(2):80-3. DOI: 10.1016/j.autrev.2010.08.006. View

10.

Lima A, Illing T, Schliemann S, Elsner P . Cutaneous Manifestations of Diabetes Mellitus: A Review. Am J Clin Dermatol. 2017; 18(4):541-553. DOI: 10.1007/s40257-017-0275-z. View

11.

Narvaez J . Systemic lupus erythematosus 2020. Med Clin (Barc). 2020; 155(11):494-501. DOI: 10.1016/j.medcli.2020.05.009. View

12.

Juarez-Rendon K, Rivera Sanchez G, Reyes-Lopez M, Garcia-Ortiz J, Bocanegra-Garcia V, Guardiola-Avila I . Alopecia Areata. Current situation and perspectives. Arch Argent Pediatr. 2017; 115(6):e404-e411. DOI: 10.5546/aap.2017.eng.e404. View

13.

Stene L, Honeyman M, Hoffenberg E, Haas J, Sokol R, Emery L . Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol. 2006; 101(10):2333-40. DOI: 10.1111/j.1572-0241.2006.00741.x. View

14.

Strazzulla L, Chun Wang E, Avila L, Lo Sicco K, Brinster N, Christiano A . Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2017; 78(1):1-12. DOI: 10.1016/j.jaad.2017.04.1141. View

15.

Karlson E, Chang S, Cui J, Chibnik L, Fraser P, De Vivo I . Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis. 2009; 69(1):54-60. PMC: 2952498. DOI: 10.1136/ard.2008.102962. View

16.

Holmes G . Coeliac disease and Type 1 diabetes mellitus - the case for screening. Diabet Med. 2001; 18(3):169-77. DOI: 10.1046/j.1464-5491.2001.00498.x. View

17.

Onengut-Gumuscu S, Chen W, Robertson C, Bonnie J, Farber E, Zhu Z . Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score. Diabetes Care. 2019; 42(3):406-415. PMC: 6385701. DOI: 10.2337/dc18-1727. View

18.

Bratanic N, Smigoc Schweiger D, Mendez A, Bratina N, Battelino T, Vidan-Jeras B . An influence of HLA-A, B, DR, DQ, and MICA on the occurrence of Celiac disease in patients with type 1 diabetes. Tissue Antigens. 2010; 76(3):208-15. DOI: 10.1111/j.1399-0039.2010.01501.x. View

19.

Nashi R, Shmerling R . Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus. Med Clin North Am. 2021; 105(2):387-396. DOI: 10.1016/j.mcna.2020.10.003. View

20.

Smith L, Burnet S, McNeil J . Musculoskeletal manifestations of diabetes mellitus. Br J Sports Med. 2003; 37(1):30-5. PMC: 1724591. DOI: 10.1136/bjsm.37.1.30. View